(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | |||||||||||
Date: | January 16, 2024 | By: | /s/ Matthew L. Daniel | ||||||||
Matthew L. Daniel, Corporate Senior Vice President, | |||||||||||
General Counsel, Corporate Secretary & Chief Compliance Officer |
Cover Page |
Jan. 09, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jan. 09, 2024 |
Entity Registrant Name | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-15943 |
Entity Tax Identification Number | 06-1397316 |
Entity Address, Address Line One | 251 Ballardvale Street |
Entity Address, City or Town | Wilmington |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 01887 |
City Area Code | 781 |
Local Phone Number | 222-6000 |
Title of 12(b) Security | Common stock, $0.01 par value |
Trading Symbol | CRL |
Security Exchange Name | NYSE |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001100682 |
Amendment Flag | false |
JU+VKAI-V@+P;LI\&[.P1N$
M(=A >O%Q0R;P'GF2E5G$%?UK2NY8%#$=OC)( CP#ST50J5=:L/=#L$/;@F6W
M5#M9Z -8?20$3;8T.P6BP^0"X99K>]
M9!:G